DermTech PE Ratio 2017-2024 | DMTKQ
Current and historical p/e ratio for DermTech (DMTKQ) from 2017 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. DermTech PE ratio as of June 28, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| DermTech PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-06-26 | 0.09 | 0.00 | |
| 2024-03-31 | 0.70 | $-2.70 | 0.00 |
| 2023-12-31 | 1.75 | $-3.14 | 0.00 |
| 2023-09-30 | 1.44 | $-3.51 | 0.00 |
| 2023-06-30 | 2.60 | $-3.90 | 0.00 |
| 2023-03-31 | 3.68 | $-3.90 | 0.00 |
| 2022-12-31 | 1.77 | $-3.89 | 0.00 |
| 2022-09-30 | 3.96 | $-3.84 | 0.00 |
| 2022-06-30 | 5.54 | $-3.56 | 0.00 |
| 2022-03-31 | 14.68 | $-3.16 | 0.00 |
| 2021-12-31 | 15.80 | $-2.70 | 0.00 |
| 2021-09-30 | 32.11 | $-2.30 | 0.00 |
| 2021-06-30 | 41.57 | $-2.12 | 0.00 |
| 2021-03-31 | 50.79 | $-2.11 | 0.00 |
| 2020-12-31 | 32.44 | $-2.09 | 0.00 |
| 2020-09-30 | 11.95 | $-1.69 | 0.00 |
| 2020-06-30 | 13.23 | $-1.99 | 0.00 |
| 2020-03-31 | 11.25 | $-1.41 | 0.00 |
| 2019-12-31 | 12.40 | $-0.88 | 0.00 |
| 2019-09-30 | 5.60 | $-0.80 | 0.00 |
| 2019-06-30 | 20.80 | 0 | 0.00 |
| 2019-03-31 | 20.64 | 0 | 0.00 |
| 2018-12-31 | 20.42 | 0 | 0.00 |
| 2018-09-30 | 20.24 | 0 | 0.00 |
| 2018-06-30 | 19.92 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.004B | $0.015B |
| DermTech Inc. markets and develops products which facilitate early detection of skin cancers, assess inflammatory diseases and customize drug treatments. DermTech Inc., formerly known as Constellation Alpha Capital Corp., is based in La Jolla, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $125.938B | 15.80 |
| Cencora (COR) | United States | $44.936B | 17.52 |
| ICON (ICLR) | Ireland | $25.860B | 24.41 |
| DiDi Global (DIDIY) | China | $20.122B | 0.00 |
| CochLear (CHEOY) | Australia | $14.423B | 0.00 |
| Avantor (AVTR) | United States | $14.400B | 21.20 |
| Natera (NTRA) | United States | $13.298B | 0.00 |
| Revvity (RVTY) | United States | $12.939B | 22.70 |
| Medpace Holdings (MEDP) | United States | $12.761B | 41.98 |
| Viatris (VTRS) | United States | $12.657B | 3.78 |
| Charles River Laboratories (CRL) | United States | $10.641B | 20.37 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.412B | 0.00 |
| Solventum (SOLV) | United States | $9.133B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.426B | 0.00 |
| HealthEquity (HQY) | United States | $7.500B | 48.16 |
| Organon (OGN) | United States | $5.323B | 5.05 |
| Doximity (DOCS) | United States | $5.186B | 36.33 |
| Bausch + Lomb (BLCO) | Canada | $5.109B | 20.45 |
| PACS (PACS) | United States | $4.496B | 0.00 |
| Life Times (LTH) | United States | $3.744B | 39.23 |
| Sotera Health (SHC) | United States | $3.360B | 16.49 |
| Surgery Partners (SGRY) | United States | $3.024B | 27.66 |
| GoodRx Holdings (GDRX) | United States | $2.927B | 111.43 |
| Progyny (PGNY) | United States | $2.724B | 46.90 |
| Agilon Health (AGL) | United States | $2.690B | 0.00 |
| Premier (PINC) | United States | $1.957B | 8.37 |
| AMN Healthcare Services Inc (AMN) | United States | $1.947B | 7.72 |
| BrightSpring Health Services (BTSG) | United States | $1.946B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.659B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.566B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.495B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.250B | 0.00 | |
| CareDx (CDNA) | United States | $0.809B | 0.00 |
| Embecta (EMBC) | United States | $0.721B | 4.90 |
| GeneDx Holdings (WGS) | United States | $0.683B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.675B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.635B | 6.74 |
| Auna S.A (AUNA) | Luxembourg | $0.591B | 0.00 |
| Sharecare (SHCR) | United States | $0.489B | 0.00 |
| Enhabit (EHAB) | United States | $0.447B | 44.60 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.413B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.381B | 0.00 |
| ModivCare (MODV) | United States | $0.373B | 6.98 |
| QDM (QDMI) | Hong Kong, SAR China | $0.353B | 9.24 |
| DocGo (DCGO) | United States | $0.314B | 17.17 |
| LifeMD (LFMD) | United States | $0.285B | 0.00 |
| MultiPlan (MPLN) | United States | $0.250B | 0.00 |
| Beauty Health (SKIN) | United States | $0.237B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.194B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.193B | 0.00 |
| Biodesix (BDSX) | United States | $0.175B | 0.00 |
| So-Young (SY) | China | $0.110B | 53.25 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.045B | 6.04 |
| Co-Diagnostics (CODX) | United States | $0.039B | 0.00 |
| Oncology Institute (TOI) | United States | $0.034B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.034B | 0.00 |
| Nutex Health (NUTX) | United States | $0.030B | 0.00 |
| OncoCyte (OCX) | United States | $0.024B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.023B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.022B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.021B | 0.00 |
| KindlyMD (KDLY) | $0.016B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.016B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.015B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Assure Holdings (IONM) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.004B | 0.00 |
| OpGen (OPGN) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |